Inventor · disambiguated record
Ai Ching Lim
Also filed as: LIM AI CHING
27 granted patents·8 pending applications·471 citations·filing 2006–2024
97Inventor score
Top patents by PatentIndex Score
35 records- 0198US7858739B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 28, 2010·84 cites·79 claims
- 0298US7767206B2Neutralizing determinants of IL-17 Receptor A and antibodies that bind theretoAMGEN INC·Filed 2007·Granted Aug 3, 2010·76 cites·8 claims
- 0397US8324362B2Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptorsCHEN YAN·Filed 2010·Granted Dec 4, 2012·58 cites·10 claims
- 0497US7847062B2Pharmacokinetic modulation and compositions for modified FN3 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 7, 2010·77 cites·15 claims
- 0596US9862758B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 9, 2018·20 cites·22 claims
- 0696US8790648B2Methods of treating psoriasis using IL-17 receptor A antibodiesTOCKER JOEL·Filed 2012·Granted Jul 29, 2014·27 cites·59 claims
- 0796US8609613B2Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptidesCHEN YAN·Filed 2012·Granted Dec 17, 2013·36 cites·20 claims
- 0895US9328157B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 3, 2016·26 cites·7 claims
- 0994US9073999B2Anti-IL-17 receptor A neutralizing antibodiesTOCKER JOEL·Filed 2010·Granted Jul 7, 2015·16 cites·4 claims
- 1092US10851144B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2016·Granted Dec 1, 2020·16 cites·10 claims
- 1190US9382318B2ST2 antigen binding proteinsAMGEN INC·Filed 2013·Granted Jul 5, 2016·10 cites·29 claims
- 1289US2025230250A1Oncostatin m receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1388US11059895B2ST2 antigen binding proteinsAMGEN INC·Filed 2019·Granted Jul 13, 2021·2 cites·38 claims
- 1488US10208122B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2016·Granted Feb 19, 2019·4 cites·5 claims
- 1588US9593163B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2016·Granted Mar 14, 2017·5 cites·16 claims
- 1688US2024368292A1St2 antigen binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 1787US9982054B2ST2 antigen binding proteinsAMGEN INC·Filed 2016·Granted May 29, 2018·4 cites·34 claims
- 1883US10995131B2Libraries of modified fibronectin type III tenth domain-containing polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 4, 2021·1 cites·14 claims
- 1981US9663571B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·3 cites·16 claims
- 2080US9309318B2Compositions relating to anti-IL-21 receptor antibodiesAMGEN INC·Filed 2013·Granted Apr 12, 2016·4 cites·6 claims
- 2178US12122837B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 22, 2024·0 cites·28 claims
- 2278US11965029B2ST2 antigen binding proteinsAMGEN INC·Filed 2021·Granted Apr 23, 2024·0 cites·36 claims
- 2378US10421813B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2017·Granted Sep 24, 2019·1 cites·12 claims
- 2477US9738721B1Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2017·Granted Aug 22, 2017·1 cites·16 claims
- 2577US2024327486A1Interleukin-2 muteins for the expansion of t-regulatory cellsAMGEN INC·Filed 2024·Application pending·0 cites
- 2675US11858999B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2020·Granted Jan 2, 2024·0 cites·4 claims
- 2773US11180564B2IL-17 Receptor A antigen binding proteinsAMGEN K A INC·Filed 2018·Granted Nov 23, 2021·0 cites·3 claims
- 2868US2019359724A1Oncostatin m receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2968US2014356355A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2014·Application pending·0 cites
- 3067US11976103B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2020·Granted May 7, 2024·0 cites·15 claims
- 3167US2010028345A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2007·Application pending·0 cites
- 3264US10227414B2ST2 antigen binding proteinsAMGEN INC·Filed 2017·Granted Mar 12, 2019·0 cites·45 claims
- 3351US10184002B2Methods and compositions relating to anti-IL-21 receptor antibodiesAMGEN INC·Filed 2016·Granted Jan 22, 2019·0 cites·21 claims
- 3447US2008220049A1Compositions and methods for intraocular delivery of fibronectin scaffold domain proteinsADNEXUS A BRISTOL MYERS SQUIBB·Filed 2007·Application pending·0 cites
- 3546US2008124340A1Erythropoietin receptor agonistsBORGES LUIS G·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ai Ching Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →